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Background: Transcatheter Ventricular septal defect (VSD) device
closure is an accepted treatment option for isolated muscular
VSDs & certain membranous VSDs.
Methods: VSD transcatheter closure was attempted in 120 pa-
tients with various devices indifferent anatomical types of VSD
between November 2008 & July 2014 using antegrade approach in
all cases except one.
Results: Twenty seven perimembranous, 64 basal-muscular, 20
mid-muscular, 6 sub-pulmonic VSDs were successfully closed. 3
patients had multiple VSDs. Median VSD size was 5 mm. Average
fluoro-time was 24min (range 12e42minutes) which decreased to
11-15min in 2013-14 with increasing operator experience. Devices
implantedwere duct occluder in 100, muscular device in 13, septal
occluder in 1, asymmetric (2 cases)& symmetric perimembranous
devices (1 case). The procedure was successful in 106 cases (91%)
with complete closure of the shunt immediate post-procedure or
within 24 hours, without any complications. Repeat echo was
done at out-patient follow up at 48 hours, 6months,& then yearly.
Surgical intervention was sought in 7 cases during the initial
learning curve (2-device embolization, 2-tricuspid regurgitation,
1-complete heart block, 1-persistent hematuria,1-significant re-
sidual shunt). Four patients with post-procedure junctional
rhythm (treated with oral steroids), 3 with asymptomatic RBBB& 2
with mild aortic regurgitation (AR) are under continuous close
follow-up. In 3 patients, the procedure was abandoned due to
intra-procedural conduction defect/arrhythmias in 2 &AR in 1.
Conclusion: Complications of transcatheter closure of congenital
VSDs are limited, mostly seen during the initial learning curve.
More experience &long-term follow-up confirm the safety & effi-
cacy as a viable alternative to surgery. This study also demon-
strates the feasibility of use of duct occluder for VSD closure,
including subpulmonic VSDs.
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Background: PVBD is the treatment of choice for congenital PV
stenosis, with proven good short term results. This review was
designed to study demographic profile of, and document early and
late outcomes after percutaneous balloon dilation (PVBD) in pa-
tients presenting to a tertiary care centre with pulmonic stenosis.
Material and Methods: Demographic, clinical and echocardio-
graphic data regarding PVBD was reviewed for patients undergo-
ing PVBD between 2001 and 2014.The dilation was done from
femoral venous access by previously described standard methods
after crossing the stenosed valve. Semicompliant Tyshak balloons
if annulus < 22 mm and Accura balloons if PV annulus > 22 mm
were used to dilate the valve with maximum BAR (Balloon-to-
annulus ratio) of 140%. PVBD procedures were done from jugular
access in 3 cases due to severe TR in RV dysfunction precluding
wire and catheter entry from RA to RV despite multiple attempts.
Successful PVBDwas defined as reduction of RV-toePA gradient >
50% with no complications.
Results: In the study period mentioned above, 1041 (M¼529:
F¼512) patients underwent PVBD of whom 82 patients underwent
the procedure twice (of these 82, 8 were Noonan phenotype). 126
patients had at least additional mild infundibular PS, 379 had a
concomitant ostium secundum ASD and 12 had tiny basal
muscular (n¼7) and 5 had small apical muscular VSD. 19 patients
were congenital rubella syndrome phenotype, and Noonan syn-
drome phenotype was seen in 32 patients, though genetic testing
was not available. The youngest patient was a 7-day oldmale child
and the oldest was 60 year old (mean age13, median age¼10.5 yrs).
PV gradients decreased from mean 78+/-30 mmHg to 24+/-19 mm
Hg (p<0.0001) and remained low during amean follow-up of 8.9+/-
3.1 (range 3.7 to 14 years).
PVBD was also done for TOF patients (n¼15), for Dysplastic
valves (n¼22), Supravalvular PS in 19 cases with PVBD and RPA
plasty done in 3 cases and Ebstein’s anomaly with valvular PS in
one case. RVOT conduit dilation for stenosed Hemashield graft
was also done in one case with post-truncal repair conduit ste-
nosis. PVBD was done for 82 patients of PS with severe RV
dysfunction and 92% patients in this group had satisfactory im-
mediate and dramatic results with RV function starting to
improve as early as 24 hours post PVBD. Concomitant ASD device
closure with PVBD was done in 11 patients.
Freedom from re-intervention at 1, 10 and 14 years were: 99%,
96%, and 91% respectively among the patients who continued to
be followed up. Moderate post-PVBD pulmonary regurgitation (PR)
occurred in upto 49% patients after PVBD but decreased during
follow-up. The gradient across the stenosed valve in successful
PVBD showed an immediate post-PVBD fall, followed by a trend to
decrease further over time due to favourable RV remodeling and
regression of RV hypertrophy. Predictors of less favourable PVBD
result requiring repeat PVBD were initial high RV-to-PA gradients
> 75 mm Hg, PVBD for dysplastic valves, PVBD in Noonan syn-
drome, presence of additional severe infundibular stenosis,
presence of hypoplastic annulus, and severe RVH.
Conclusions: Starting even from neonatal PS, PVBD is an effica-
cious procedure for treatment of congenital pulmonic stenosis
with satisfactory short and long term results in patients, and is
associated with immediate fall in PV gradients and dramatic
improvement of RV function,though RVH regression occurs in
majority of patients over a longer time period. Although post-
PVBD PR occurs commonly, it is well tolerated and decreases
eventually over time. Even in patients with an initial favourable
result, gradients continue to declinewith continued favourable RV
remodeling indicating that immediate post-PVBD gradient alone
may not be the only predictor of longer term favourable outcomes.
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Background: As the Tetralogy of Fallot (TOF) is the most common
cyanotic heart disease, and the anatomy of pulmonary artery is
the key determinant for surgical repair, precise assessment of
pulmonary artery by some readily available harmless simple
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